Aytu BioPharma, Inc. (NASDAQ: AYTU) is a pharmaceutical company focused on commercializing novel therapeutics. The Company is witnessing increasing market support for its attention deficit hyperactivity disorder (ADHD) Portfolio and Pediatric Portfolio and is thus focusing its resources on these rapidly growing products. Aytu BioPharma, Inc....
Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated approaches, advanced scientific knowledge and a zeal for innovation to the table. Our biotech picks this week are making strides in fields such as immune-oncology, ocular...
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) develops Anticalin-based drugs for treatment of conditions related to immuno-oncology and respiratory diseases such as Asthma and Anaemia. Anticalin proteins are engineered versions of lipocalins that are human proteins having the ability to bind, store and transport molecules, which the Company has...
Alopecia Areata is an autoimmune/polygenic skin disease that causes loss of hair on the scalp and face and is estimated to affect over 6.8 million people in the U.S alone. There is currently no cure available for this disorder, with dermatologists using Corticosteroids, minoxidil 5%,...
